Outlook of IL-6 signaling blockade for COVID-19 pneumonia.

Minor positive trends were observed in the primary pre-specified analysis group (critical patients on sarilumab 400 mg who were mechanically ventilated at baseline) that did not reach statistical significance, and these were countered by negative trends in a subgroup of critical patients who were not mechanically ventilated at baseline.

also in 111,027 other papers